Details

NameSymbolSector
TRIDENT TEXOFAB LIMITEDTTFLOther Textile Products
Open
338.5
High
338.55
Low
338.5
Close
338.55
Volume
23527
Exchange
bse
Time
03-Oct-2025

Outlook

Score:  

3.5

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Trident Texofab is  
Doji
Estimated Stoploss of Trident Texofab is ₹  
338.5
Trident Texofab has a  
Bullishℹ
 pattern. 
Formation of  
Doji
 candle pattern indicates the trend direction of Trident Texofab is  
Unpredictableℹ
. 

Trend

Trident Texofab is in  
Uptrendℹ
. 
Price of Trident Texofab is  
Upℹ
 by  

26.28

%. 
Target
Buy @ 

210

Sell @ 

338.55

Current @ 

338.55

Volume

The trade volume of Trident Texofab has been  
Goodℹ
Though the volume trend for Trident Texofab appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Trident Texofab is  

Up

 by  

48.44

% 

Valuation

The current market price of Trident Texofab is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 100cr and total assets worth ₹ 100cr, the balance sheet of Trident Texofab is:  
Balancedℹ
. 
Cashflow
Trident Texofab has  
Sufficientℹ
 cash flow because there is  

Surplus

 of  

₹ 5cr

. It is  
Upℹ
 by  

0

%. 

(*Mar 2025)

40.63% i.e. ₹ 13cr spent in operatingℹ
3.13% i.e. ₹ 1cr earned in investingℹ
56.25% i.e. ₹ 18cr earned in financingℹ
0% in otherℹ
Trident Texofab has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

50% i.e. ₹ 2cr earned in operatingℹ
0% in investingℹ
50% i.e. ₹ 2cr spent in financingℹ
0% in otherℹ
Income
The income of Trident Texofab is  

₹ 28cr

 and  

Profit

 is :  

₹ 1cr

(*Jun 2025)

Trident Texofab Profit is up by:  

100

% and Income is Down by:  

26.32

% 

(*Jun 2025)

The income of Trident Texofab is  

₹ 38cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Trident Texofab Losses increased by:  

0

% and Income is Up by:  

22.58

% 

(*Mar 2025)

The income of Trident Texofab is  

₹ 31cr

 and  

Loss

 is :  

₹ 0cr

(*Dec 2024)

Trident Texofab Losses increased by:  

100

% and Income is Up by:  

6.9

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.